Clinical features and outcome of patients with apical hypertrophic cardiomyopathy in Taiwan

Cardiology

Volumn 106, Issue 1, 2006, Pages 29-35

  Lee, Cheng Han ^a   Liu, Ping Yen ^a   Lin, Li Jen ^a   Chen, Jyh Hong ^a   Tsai, Liang Miin ^a  

^a NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Hypertrophic cardiomyopathy; Left ventricular hypertrophy; Transthoracic echocardiography

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; WARFARIN;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL FEATURE; FEMALE; FOLLOW UP; HEART HYPERTROPHY; HEART LEFT ATRIUM; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; JAPAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SEX DIFFERENCE; SYNCOPE; TAIWAN; TRANSTHORACIC ECHOCARDIOGRAPHY; TREATMENT OUTCOME;

AGE OF ONSET; ASIAN CONTINENTAL ANCESTRY GROUP; CARDIOMYOPATHY, HYPERTROPHIC; CORONARY ANGIOGRAPHY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; LOGISTIC MODELS; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; TAIWAN;

EID: 33745727901     PISSN: 00086312     EISSN: None     Source Type: Journal    
DOI: 10.1159/000092590     Document Type: Article

References (22)

1. Sakamoto T, Tei C, Murayama M, Ichiyasu H, Hada Y: Giant T wave inversion as a manifestation of asymmetrical apical hypertrophy (AAH) of the left ventricle: echocardiographic and ultrasono-cardiotomographic study. Jpn Heart J 1976;17:611-629.
2. Yamaguchi H, Ishimura T, Nishiyama S, Nagasaki F, Nakanishi S, Takatsu F, Nishijo T, Umeda T, Machii K: Hypertrophic nonobstructive cardiomyopathy with giant negative T waves (apical hypertrophy): ventriculographic and echocardiographic features in 30 patients. Am J Cardiol 1979;44:401-412.
3. Sakamoto T, Amano K, Hada Y, Tei C, Takenaka K, Hasegawa I, Takahashi T: Asymmetric apical hypertrophy, ten years experience. Postgrad Med J 1986;62:567-570.
4. Moro E, D'Angelo G, Nicolosi GL, Mimo R, Zanuttini D: Long-term evaluation of patients with apical hypertrophic cardiomyopathy. Correlation between quantitative echocardiographic assessment of apical hypertrophy and clinical-electrocardiographic findings. Eur Heart J 1995;16:210-217.
5. Webb JG, Sasson Z, Rakowski H, Liu P, Wigle ED: Apical hypertrophic cardiomyopathy: clinical follow-up and diagnostic correlates. J Am Coll Cardiol 1990;15:83-90.
6. Eriksson MJ, Sonnenberg B, Woo A, Rakowski P, Parker TG, Wigle ED, Rakowski H: Long-term outcome in patients with apical hypertrophic cardiomyopathy. J Am Coll Cardiol 2002;39:638-645.
7. Cubukcu AA, Scott PJ, Williams GJ: Apical hypertrophic cardiomyopathy presenting as acute subendocardial myocardial infarction. Int J Cardiol 1993;38:329-332.
8. Partanen J, Kupari M, Heikkila J, Keto P: Left ventricular aneurysm associated with apical hypertrophic cardiomyopathy. Clin Cardiol 1991;14:936-939.
9. Wilson P, Marks A, Rastegar H, Manolis AS, Estes NA: Apical hypertrophic cardiomyopathy presenting with sustained monomorphic ventricular tachycardia and electrocardiographic changes simulating coronary artery disease and left ventricular aneurysm. Clin Cardiol 1990;13:885-887.
10. Louie EK, Maron BJ: Apical hypertrophic cardiomyopathy: clinical and two-dimensional echocardiographic assessment. Ann Intern Med 1987;106:663-670.
11. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JC, Jones DW, et al: The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003;289:2560-2572.
12. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, Gutgesell H, et al: Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcomittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989;2:358-367.
13. Panza JA, Petrone RK, Fananapazir L, Maron BJ: Utility of continuous wave Doppler echocardiography in the noninvasive assessment of left ventricular outflow tract pressure gradient in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 1992;19:91-99.
14. Cohen JL, Cheirif J, Segar DS, Gillam LD, Gottdiener JS, Hausnerova E, Bruns DE: Improved left ventricular endocardial border delineation and opacification with OPTISON (FS069), a new echocardiographic contrast agent. Results of a phase III multicenter trial. J Am Coll Cardiol 1998;32:746-752.
15. Wang DW, Deng YB: Hypertrophic cardiomyopathy complicated by severe bradycardias: a pedigree report. Clin Cardiol 2002;25:76-80.
16. Fang BR, Chiang CW, Lee CP, Lee YS: Apical hypertrophic cardiomyopathy: clinical, echocardiographic and angiographic features in 3 Chinese patients. J Formos Med Assoc 1990;89:383-387.
17. Maron BJ: Hypertrophic cardiomyopathy: a systemic review. JAMA 2002;287:1308-1320.
18. Kitaoka H, Doi Y, Casey SA, Hitomi N, Furuno T, Maron BJ: Comparison of prevalence of apical hypertrophic cardiomyopathy in Japan and the United States. Am J Cardiol 2003;92:1183-1186.
19. Koga Y, Itaya K, Toshima H: Prognosis in hypertrophic cardiomyopathy. Am Heart J 1984;108:351-359.
20. Sakamoto T: Apical hypertrophic cardiomyopathy: an overview. J Cardiol 2001;37(suppl 1):161-178.
21. Maron BJ, Bonow RO, Seshagiri TN, Roberts WC, Epstein SE: Hypertrophic cardiomyopathy with ventricular septal hypertrophy localized to the apical region of the left ventricle (apical hypertrophic cardiomyopathy). Am J Cardiol 1982;49:1838-1848.
22. Koga Y, Katoh A, Matsuyama K, Ikeda H, Hiyamuta K, Toshima H, Imaizumi T: Disappearance of giant negative T waves in patients with the Japanese form of apical hypertrophy. J Am Coll Cardiol 1995;26:1672-1678.